STERIS to Present at the Morgan Stanley Healthcare Conference
August 30, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND , Aug. 30, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) ("STERIS" or the "Company") announced that it will participate in the Morgan Stanley Healthcare Conference in New York...
STERIS Completes the Acquisition of Surgical Instrumentation Assets from BD
August 02, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical...
STERIS Announces Financial Results for Fiscal 2024 First Quarter
August 01, 2023 16:30 ET
|
STERIS plc
First quarter revenue growth of 11% as reported and constant currency organicAs reported diluted earnings per share increased to $1.25; adjusted earnings increased to $2.00Fiscal 2024 outlook updated...
STERIS Raises Dividend to $0.52 per share
July 26, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND , July 26, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.52 per...
STERIS to Host a Conference Call for Fiscal 2024 First Quarter Financial Results on August 2, 2023
July 19, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND, July 19, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2024 first quarter...
STERIS Expands Healthcare Products Offering with Acquisition of Surgical Instrumentation Assets from Becton, Dickinson and Company for $540 million
June 20, 2023 08:00 ET
|
STERIS plc
A natural extension for STERIS in the operating room and sterile processing departmentA primarily consumables product portfolioTransaction expected to close by September 30, 2023 DUBLIN, IRELAND ,...
STERIS Announces Financial Results for Fiscal 2023 Fourth Quarter and Full Year
May 10, 2023 16:30 ET
|
STERIS plc
Fourth quarter as reported revenue increased 14%; 16% constant currency organic revenue growthFourth quarter as reported earnings per share of $1.88; adjusted EPS of $2.30Fiscal 2024 Outlook Provided ...
STERIS Appoints Esther M. Alegria, Ph.D. to Board of Directors
May 03, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND, May 03, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that Esther M. Alegria, Ph.D. has been elected to the Board of Directors,...
STERIS Announces $500 million Share Repurchase Authorization and Declares $0.47 per share Dividend
May 03, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND, May 03, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that STERIS's Board of Directors has authorized a new share buyback program for...
STERIS to Host a Conference Call for Fiscal 2023 Fourth Quarter and Full Year Financial Results on May 11, 2023
April 24, 2023 16:30 ET
|
STERIS plc
DUBLIN, IRELAND, April 24, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 fourth quarter...